Docetaxel

Details About Generic Salt ::  Docetaxel  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS DOCETAXEL SEMISYNTHETIC TAXANE | ANTI-NEOPLASTIC PK: D: 80-90 L/m2 (Vd),...

Doxorubicin

Details About Generic Salt ::  Doxorubicin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS DOXORUBICIN ANTHRACYCLINE | ANTI-NEOPLASTIC PK: A: Poor D: Extensive,...

Gefitinib

Details About Generic Salt ::  Gefitinib  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS GEFITINIB EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR | ANTI-NEOPLASTIC PK:...

Anastrozole

Details About Generic Salt ::  Anastrozole  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS ANASTROZOLE NONSTEROIDAL AROMATASE INHIBITOR | ANTI-NEOPLASTIC PK: A:...

Gemcitabine

Details About Generic Salt ::  Gemcitabine  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS GEMCITABINE ANTIMETABOLITE (PYRIMIDINE ANALOG) | ANTI-NEOPLASTIC PK: D:...

Ifosfamide

Details About Generic Salt ::  Ifosfamide  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS IFOSFAMIDE ALKYLATING AGENT, NITROGEN MUSTARD | ANTI-NEOPLASTIC PK: D:...

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.

I accept I decline